echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Health and Planning Commission: Drug procurement budget bans hospital business expenditure by 25%-30%

    Health and Planning Commission: Drug procurement budget bans hospital business expenditure by 25%-30%

    • Last Update: 2021-02-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Drug prices are inflated, hospital drug tenders and procurement are out of touch, "low-cost drugs" are becoming more and more difficult to buy ... In order to crack these problems, the State Health and Planning Commission yesterday issued "on the implementation of the improvement of public hospitals drug centralized procurement guidance notice", detailed the public hospital drug procurement reform measures. In the future, the procurement of drugs in public hospitals is no longer a one-size-fits-all approach, but to take tenders, negotiations and other five procurement measures to "drug the disease" to solve the above-mentioned problems.
    , public hospitals are the main channel of drug sales, accounting for more than 80% of the national drug market share. This means that how public hospitals buy medicines in the future affects every patient's wallet. The reform will achieve two objectives, first, to reduce drug prices and, second, to secure the supply of medicines.first mentioned the establishment of drug price negotiation mechanism
    Since 2006, China has implemented the centralized procurement of drugs on-the-internet in provinces (regions and cities). However, hospital drug bidding and procurement is out of touch, some drug prices are not low, drug rebates, commercial bribery cases are frequent. The circular urged the provinces to formulate specific implementation measures to ensure that a new round of centralized procurement of medicines was initiated during the year.
    highlight of this reform is the implementation of classified procurement according to the situation of drug supply security, public hospitals will be through tender procurement, negotiation procurement, hospital direct procurement, fixed-point production, special drug procurement in different ways centralized procurement of drugs.
    experts said that the price negotiation mechanism was first proposed, is to play a market role in the practice. The advantage of classified procurement is that, on the one hand, the market moderately adjusts the price of low-cost drugs to encourage manufacturers to produce them, on the other hand, for special drugs, the government can use administrative means to ensure supply.
    Hong, director of the pharmaceutical administration department of the State Health and Planning Commission, said hospitals should not organize separate bargaining for purchase prices formed through tender negotiations, fixed-point production and other means. In addition, the list of pharmaceutical enterprises that set up settlement accounts in hospitals will be published to the public on a regular basis.
    new procurement system requires increased budget constraints, and future hospital drug expenditure is generally not higher than 25% to 30% of hospital operating expenses. This is to control the cost of drugs from the budget link, which is conducive to reducing the inflated price of drugs.of patented and exclusive drugs will be reduced by 10 billion
    how many benefits will the public enjoy when the new procurement system is implemented? How much can a inflated drug price knock out?
    Zhenghong said that patented and exclusive drugs are widely negotiated internationally, either in exchange for market prices or through increased health care payments. For example, in China's public hospitals to purchase Western medicine, imported more than 60 kinds of patented drugs. In addition, there are 1560 kinds of drugs that have passed the patent period and are not manufactured by imitation in China. It has been estimated that the total sales of patented drugs and exclusive varieties should be more than 60 billion to 70 billion in the market. With the implementation of the policy, the $670 billion in drugs could reduce spending by more than $10 billion.focus 1 drug price inflated will be cracked?
    , director of the drug administration department of the State Health and Planning Commission, said that in the past, there were falsely high prices on the drug procurement platform of public hospitals, and there were some problems with integrity.
    believes that the reasons for this phenomenon are related to the previous procurement methods. In the past, the public hospital drug procurement approach, popularly speaking, is centralized finalists, decentralized procurement, did not achieve a real centralized procurement, recruitment is separated, the volume price is not linked.
    Mr Zheng said the new system changed the old practice of including all medicines in tenders, such as the way patented drugs and exclusive varieties were previously tendered, and rather negotiated procurement. This is due to the lack of competition in the market for such drugs and the widespread international approach to negotiation.
    In addition, he stated that the scope of medicines included in the tender procurement had been further narrowed, not by recruiting all the drugs, but by emphasizing that no less than 80 per cent of the previous year's procurement amounts should be included in the tender procurement. It is intended to bring high-priced drugs, many produced drugs, and drugs that reflect inflated prices in society, through the market approach, through bidding methods, to return it to a reasonable price range.focus 2 low-cost drugs for children how to protect?
    , some low-cost drugs, such as thyroid patients, are becoming more and more difficult to buy. How to ensure that low-cost drugs are no longer difficult to find?
    , according to Zheng Hong, in order to ensure the supply of low-cost drugs, the future commonly used low-cost drugs are not included in the tender procurement of drugs, but directly online procurement. By the provincial drug procurement agencies will have the corresponding qualifications of enterprises directly linked to the network, hospitals directly with enterprises to bargain for procurement. After the introduction of policy measures for commonly used low-cost drugs, the prices of such drugs will be generally stable. In terms of supply security, many companies will resume producing low-cost drugs because they still bring profits to them.
    in children's medicine, at present, China's children-specific drugs less than 10%, paediatric clinical drugs are in short supply. Some media have said that Chinese children "use drugs by slugs, doses by guessing".
    Zhenghong said that the research found that at all levels of medical institutions, the specialty drug use of women and children should first be based on the protection of quality, security of supply. The new procurement system proposes that women's and children's specialist drugs be put directly on the internet and that the bidding process should no longer be followed, as there are concerns that bidding will affect the supply of specialist drugs.
    he introduced, some foreign drug instructions can be clearly used on children, China did not do clinical observation in this regard, but some pediatricians after a long period of clinical diagnosis and treatment has groped out the law of drug use. We now entrust industry associations to sum up the experience in this regard, form an industry consensus, to provide the national drug registration management departments, so that they through the improvement of drug specifications and other forms to guide enterprises to produce the corresponding specifications. focus 3 drug price information sharing will be achieved?
    present, china's centralized drug procurement platform still lacks unified construction standards, functional norms and procurement codes, between the state and the province, between the provinces have not been all connected. In 2014, the state has started the construction of an integrated management information system for drug supply security, and has now achieved up-and-down transmission with five provinces (regions and cities) such as Tianjin.
    Zhenghong said, the first is to achieve the provincial procurement platform and the national drug management platform connection, in November this year to achieve all provinces interconnected, resource sharing. Information sharing is very important to get rid of the role of "drug prices are inflated", because drug prices in previous provinces are not interoperable, there have been some enterprises in different provinces of the same drug prices. There is also a lack of data support for the much-maligned "inflated drug price".
    information connection, the sales and price of a certain enterprise in a certain place are open and transparent to all provinces of the country. In order to strengthen the supervision of the upper level of the market, but also conducive to medical institutions in the procurement of drugs have the corresponding data support. Especially in the future, a considerable number of drugs to be purchased by the hospital independently online, so the flow of information is very important. Hospital response "The operation of the new procurement system is stronger and more looking forward to supporting policies
    yesterday, Beijing University People's Hospital Vice President Ding Jie told the Beijing News reporter, the new procurement system is very operational, but the hospital is more looking forward to the introduction of relevant policies, in order to achieve the most ideal goal of medical reform. Ding Jie said that in the future drug prices will certainly be lower, hospital profits will also fall, so more supporting policies are needed. From the hospital's point of view, the new procurement system can not solve all the problems of medical reform. She believes that in the reform of health care, hospitals are really feeling the problem of compensation mechanism, how to better link with health care, "I believe there will be policies, if we can be more closely linked, faster will be better." (Pharmaceutical Network)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.